Compliance, Traceability and Speed in MedTech Product Development

Introducing Wealthing Founder Services: As part of the Wealthing VC Club’s commitment to supporting our portfolio companies beyond capital, we are launching a new educational series designed to connect founders with trusted partners across critical areas of growth. Drawing on years of deep industry experience and relationships, we have curated a lineup of webinars featuring operators and solution providers we know and trust—giving startups direct access to proven tools, insights, and strategic support. It’s our way of strengthening partnership in the startup ecosystem, and helping our companies to scale smarter and faster.

Joining us will be Nader Fathi, CEO of Enlil, to share his insights on the FDA clearance process, and how Enlil's structure can help to streamline the path to this milestone. Enlil offers a cloud‑native, AI‑powered development traceability platform that addresses the challenges of fragmentation and inefficiency by unifying documentation, compliance, collaboration, and audit readiness—making development faster, more transparent, and more scalable.

In this session, you’ll learn how to:

• Set up your documentation and traceability for FDA success—starting at the prototype stage
• Use Enlil’s unified platform to manage DHF, QMS, and design controls in one place
• Avoid common compliance pitfalls that slow down 510(k), De Novo, or PMA submissions
• Equip your team (and investors) with real-time visibility into regulatory progress

Whether you're a first-time founder or a repeat builder in regulated innovation, this webinar will help you turn regulatory planning into a strategic advantage.

Wealthing VC Club LinkedIn: https://www.linkedin.com/company/wealthing-vc-club/

Enlil: https://enlil.com/